Susquehanna International Group’s Inozyme Pharma INZY Stock Holding History

Susquehanna International Group’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,100	Closed	-$123K	–	12620
2024 Q1	$123K	Buy	+16,100	New	+$88.3K	﹤0.01%	11076
2023 Q4	–	Sell	-81,200	Closed	-$341K	–	12812
2023 Q3	$341K	Buy	81,200 +55,700	+218%	+$283K	﹤0.01%	9082
2023 Q2	$142K	Sell	25,500 -9,000	-26%	-$53.2K	﹤0.01%	10626
2023 Q1	$198K	Buy	+34,500	New	+$91.2K	﹤0.01%	10609

Susquehanna International Group's INZY Position: Q3 2025 in Review

Susquehanna International Group sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 224,981 shares — an estimated $900K sold.

Susquehanna International Group first reported a position in INZY in Q3 2020 and held it in 9 quarters. The position peaked at $900K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Susquehanna International Group reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 224,981 Inozyme Pharma shares in Q3 2025, an estimated $900K.
Susquehanna International Group first reported a position in Inozyme Pharma in Q3 2020 and held it in 9 quarters.
Susquehanna International Group's Inozyme Pharma position peaked at $900K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.